Premium
Medical radiation exposure and breast cancer risk: Findings from the Breast Cancer Family Registry
Author(s) -
John Esther M.,
Phipps Amanda I.,
Knight Julia A.,
Milne Roger L.,
Dite Gillian S.,
Hopper John L.,
Andrulis Irene L.,
Southey Melissa,
Giles Graham G.,
West Dee W.,
Whittemore Alice S.
Publication year - 2007
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.22668
Subject(s) - medicine , breast cancer , odds ratio , family history , cancer , population , cancer registry , radiation therapy , gynecology , oncology , obstetrics , environmental health
Moderate to high‐dose radiotherapy is known to increase the risk of breast cancer. Uncertainties remain about the effects of low‐dose chest X‐rays, particularly in individuals at increased genetic risk. We analyzed case‐control data from the Breast Cancer Family Registry. Self‐reported data on therapeutic and diagnostic radiation exposures to the chest were available for 2,254 breast cancer cases and 3,431 controls (1,556 unaffected sisters and 1,875 unrelated population controls). We used unconditional logistic regression analyses to estimate odds ratios (OR) and 95% confidence intervals (CI) associated with radiation exposure, after adjusting for age, study center, country of birth, and education. Increased risks for breast cancer were found for women who had radiotherapy for a previous cancer (OR = 3.55, CI = 1.47–8.54) and diagnostic chest X‐rays for tuberculosis (OR = 2.49, CI = 1.82–3.40) or pneumonia (OR = 2.19, CI = 1.38–3.47). Risks were highest for women with a large number of exposures at a young age or exposed in earlier calendar years. There was no evidence of increased risk associated with other diagnostic chest X‐rays (not including tuberculosis or pneumonia), both in women with and without indicators of increased genetic risk ( i.e. , diagnosed at age <40 years or family history of breast cancer). Given the widespread and increasing use of medical diagnostic radiation, continued surveillance of breast cancer risk is warranted, particularly in women at specific genetic risk, such as those carrying mutations in BRCA1 or BRCA2 . © 2007 Wiley‐Liss, Inc.